Paul Trampont, Ph.D.

Senior Scientific Director
Moderna, Inc.

Poster(s):

• (M0930-02-10) Multiplexed Cytokine Measurements in Culture Supernatants upon Ex Vivo Stimulation of Human PBMCs to Assess Cellular Immune Response in Vaccine Studies
  Monday, October 21, 2024

  9:30 AM – 10:30 AM MT

• (M1330-02-12) Multi-Strain Sars-Cov-2 Neutralization Assay Qualification
  Monday, October 21, 2024

  1:30 PM – 2:30 PM MT

• (T1530-02-08) Development and Fit-for-Purpose(FFP) Validation of a 35-Color Ex Vivo Stimulation and Activation-Induced Marker (AIM) Assay to Assess Vaccine-Induced Immune Responses in Human Vaccine Trials
  Tuesday, October 22, 2024

  3:30 PM – 4:30 PM MT